Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancerShuang Qiao, Peng Huang, Christophe Glorieux et al.|Oncogene|2021Cited by 27
Wild-type IDH2 is a therapeutic target for triple-negative breast cancerJiangjiang Li, Peng Huang|Nature Communications|2024Cited by 27